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        OBJECTIVES
1. To study the long term survival of patients with squamous cell 
carcinoma of the penis, treated at Cancer Institute(WIA)
2. To identify prognostic factors influencing survival in these 
patients.
3. To study outcomes of node negative patients, their patterns of 
failure and analyze prognostic factors.
4. To study outcomes of node positive patients, their outcomes 
with respect to the extent of nodal involvement and other 
prognostic factors.
5. To risk stratify node negative patients according to primary 
tumor pathological “T” status and grade, and identify subgroups 
who will benefit from prophylactic lymphadenectomy.
                         REVIEW OF LITERATURE
EPIDEMIOLOGY
The  most  common  malignant  tumor  of  the  penis  is  squamous  cell 
carcinoma.  Other  malignant  tumors  though  rare  include,  basal  cell 
carcinoma  1,  melanoma  2,  sarcomas  (most  common  are  the 
hemagioendothelioma, followed by neural, myogenic and fibrous tumors) 
3,  Paget’s  disease  4,  surface  adeno  squamous  carcinoma  5,  lympho 
reticular malignancies 6, and finally, metastases (most commonly from 
the bladder, prostate and rectum) 7.
The incidence rates of squamous cell carcinoma of the penis 
in  India  are  as  follows  0.88/100,000  population  (crude 
incidence  rate),1.23/100,000  population  (Age  standardized 
(world) rate),and 0.17 % cumulative risk  8.Among the nine 
population  based  cancer  registries  in  India,  the  Madras 
Metropolitan  Tumor  Registry(MMTR)shows  the  highest 
incidence  rates.  Crude  incidence  rate  of  1.43/100,000 
population,  Age  Standardized  Rate  of  1.81/100,000 
population and a cumulative risk of 0.23 %.
The peak incidence rate is in the 55-64 yrs and 70 to 74 
years  age  range  8.  The  tumor  has  also  been  reported  in 
children9 . 
ETIOLOGY:
Incidence  of  squamous  cell  carcinoma  of  the  penis  is 
related to the practice of neonatal circumcision, phimosis, 
hygienic  sexual  practice,  Human  Papilloma  Virus  (HPV) 
infection,  number  of  sexual  partners  and  exposure  to 
tobacco.10
Neonatal  circumcision  has  been  well  established  as  a 
prophylactic  measure  that  virtually  eliminates  the 
occurrence of penile carcinoma ,because it eliminates the 
closed  preputial  environment  where  penile  carcinoma 
develops.  The  chronic  effects  of  smegma  ,a  byproduct  of 
bacterial action on desquamated cells that are within the 
preputial sac,has been proposed as an etiological agent.. 
However, that human smegma itself as a carcinogen has not 
been established11. Penile carcinoma is extremely uncommon 
among  communities  that  practice  ritual  neonatal 
circumcision, example, Jewish populations. In India it is 
rare among the neonatally circumcised Jewish poulation but 
somewhat more common among Muslims who practice prepubertal 
circumcision. It is quite common among the uncircumcised 
Hindu and Christian population.12
Recent data have provided corroborative evidence to support 
a role for HPV in the pathogenesis of penile squamous cell 
carcinoma. However the low prevalence of penile carcinoma 
compared  with  cervical  carcinoma  has  made  the  study  of 
causative agents difficult. HPV has been detected in 15-80% 
of penile carcinoma specimens13. In a recent study of 156 
patents , the presence HPV DNA was assessed in 42 cases of 
invasive squamous cell carcinoma of the penis, 13 cases of 
carcinoma  in  situ,  25  cases  of  Balanitis  Xerotica 
Obliterans(BXO), 29 routine neonatal circumcision specimens 
and 32 adult circumcision specimens14. High risk types ie.16 
and  18  were  associated  with  penile  carcinoma.  HPV  -16 
genetic sequence was identified in 80-90% of the specimens 
and  HPV-18  in  only  10%.HPV  DNA  was  identified  in 
55%invasive  cancer,92%  carcinoma  insitu,  4%  BXO,9%  adult 
circumcision  specimens  and  none  of  the  neonatal 
circumcision specimens.
Studies have reported that cigarette smoking is risk factor 
for penile cancer. In one study 15, all forms of tobacco use 
were  found  to  be  significant  risk  factors  for  penile 
carcinoma, even after adjusting for their confounding. A 
clear dose response relationship for smoking and chewing 
was observed.
DIAGNOSIS:
The diagnosis of penile cancer is usually established by an 
adequate  wedge  biopsy  from  the  primary  tumor. 
Histopathological  features  of  depth  of  invasion, 
lymphovascular  invasion,  grade,  are  mandatory  before 
starting treatment because of the implications that these 
parameters  can  have  in  choosing  a  particular  treatment 
modality 16.
GRADING:
Squamous  cell  carcinomas  are  graded  using  Broder’s 
classification  17, which was originally described for skin 
tumors  but  has  been  adapted  for  use  in  squamous  penile 
cancer also. Four grades were originally described, but it 
is  common  for  authors  to  modify  it  into  a  three  tier 
grading  system  based  on  cell  differentiation  with 
keratinization,  keratin  pearls,intercellular 
bridges,mitotic  activity,necrosis,lymphatic  and  perineural 
invasion.
STAGING:
From  a  historical  point  of  view  ,the  Jackson’s  staging 
system  represents  the  “original”  penile  cancer  staging 
system  18.However  the  more  recent  unified  UICC/American 
Joint  Committee  on  Cancer(AJCC)  TNM  systems  are  most 
commonly used in contemporary series.19
In patients with primary penile cancer both the primary and 
regional  nodes  can  be  assessed  well  by  palpation.  Some 
studies  have  compared  physical  examination,CT  scan  and 
lymphangiography to assess regional nodes. The sensitivity 
and specificity of clinical examination were 82% and 79% 
respectively, that of CT scan was 36% and 100% respectively 
and Lymphangiography had a sensitivity of 31%20.
TREATMENT:
TREATMENT OF THE PRIMARY TUMOR:
The primary tumor in the penis can be managed based on its 
extent by21
1.circumcision
2.wide excision with skin grafts
3.partial penectomy
4.total penectomy
5.Mohs micrographic surgery
Tumors confined to the prepuce can be managed with wide 
circumcision with 2 cm margin clearance. Selected cases of 
superficial carcinoma of the penis can be treated by wide 
excision and reconstruction with a defatted full thickness 
skin graft or scrotal skin. The glans is the most common 
site  for  penile  tumors  and  local  excision  results  in 
recurrence  in  approximately  40%  of  the  patients 
22Alternatively  selected  lesions  can  be  excisied  with  a 
minimum  amount  of  normal  tissue  using  Mohs  micrographic 
surgery-fixed  tissue  technique  and  frozen  section 
technique23.Carcinomas  of  the  glans  and  penile  shaft  are 
best  managed  by  partial  penectomy  excising  1.5  to  2cm 
normal tissue proximal to the margin of the tumor. This 
should  leave  a  2.5  cm  to  3  cm  penile  stump  o  allow 
directable micturition in a standing position ,often with 
some  coital  function  as  well.  For  more  proximal  tumors 
,when a useful stump cannot be provided, total penectomy is 
done.
ANATOMY OF THE LYMPHATIC DRAINAGE OF THE PENIS:
Rouviere summarized that the first lymphoid echelon for the 
lymphatics of the penis are 
1. for the integuments of the penis,the superficial 
inguinal  nodes,particularly  those  of  the 
superomedial group
2. for the glans , the same superomedial superficial 
inguinal  group  or  the  deep  inguinal  nodes  and 
occasionally  the  external  iliac  or  hypogastric 
nodes.
3. for  the  corpora,the  superficial  inguinal 
nodes,sometimes the deep inguinal and retrofemoral 
external iliac nodes.
In  Cabanas’  study  of  lymphangography  through  the  dorsal 
lymphatics  in  43  patients  ,the  drainage  occurred  into  a 
lymph node frequently located anterior or medial aspect of 
the  superficial  epigastric  vein  corresponding  to  the 
superficial  epigastric  group  and  located  medial  to  and 
above  the  epigastric  –saphenous  junction.  In  all  the 
patients with penile cancer and metastases,this “sentinel 
node”  was  found  to  have  metastases.  In  12  %  cases 
lymphnodes  in  both  sides  were  opacified.  There  were  no 
identifiable  prepubic  nodes  or  lymph  vessels  draining 
directly into the deep inguinal nodes.
MANAGEMENT OF THE REGIONAL NODES :
The presence and extent of metastasis to the nodes in the 
inguinal region are the single most important prognostic 
factors  for  survival  in  patients  with  squamous  penile 
cancer. The biology of squamous penile cancer is such that 
it exhibits a prolonged locoregional phase before distant 
dissemination , providing a rationale for the therapeutic 
value of lymphadenectomy.
Factors predicting lymphatic metastasis:
An  essential  problem  in  managing  patients  with  penile 
cancer is the unreliability of clinical methods to detect 
lymph  node  metastases  at  an  early  stage.  Clinical 
evaluation  has  a  false  negative  rate  of  20-39%.  Further 
pathological examination has shown no tumor in 40% to 50% 
of patients with inguinal lymph node enlargement. 
The  easiest  method  to  confirm  lymph  node  metastasis  in 
clinically  node  positive  patients  is  by  fine  needle 
aspiration. False negative rates can occur in upto 15% of 
cases.If  negative,  another  FNAC  is  recommended  after  a 
brief  delay..  If  negative  again  and  clinical  suspicion 
remains, an excision biopsy is advised.26.some authors have 
attempted  to  risk  stratify  clinically  node  negative 
patients based on primary tumor stage and grade in order to 
select  patients for lymphadenectomy.27
Low Risk -Tis,T1 Grade1(0%)
Intermediate Risk -T1 Grade3
-T1 Grade2(25%)
-T2 Grade1(41.2%)
High Risk -T2 Grade2(73.3%)
-T2 Grade3(100%)
Modified from reference 27.(Number of patients who where 
pN1-3  indicated  in  parentheses).Total  number  of  patients 
studied were 66 in the retrospective group and 37 in the 
prospective group.
Prognostic  significance  of  the  presence  and  extent  of 
inguinal nodal metastasis:
Data collected from 24 surgical series over 37 years period 
show that the average 5 years survival in patients proved 
to  have  no  inguinal  metastases  either  by  histological 
examination orrepeated clinical examination over time, was 
73%(46%  to  100%).  In  patients  with  resected  inguinl 
metastases, the 5 yrs survival averaged 60%(0-86%),but this 
varied widely and was direcly attributable to the extent of 
nodal metastases present. Those with 2 or less nodes 81% 
and for those with more than 2 nodes ,the 5yrs survival was 
50%(7 to 54%)28
Taken  together  tha  data  suggest  that  the  pathological 
criteria associated with long term survival after attempted 
curative resection of inguinal lymph node metastases ( 80 % 
5 years survival) include 
1. minimal nodal disease ( upto two involved nodes)
2. unilateral involvement
3. no evidence of extranodal extension of cancer.30
4. absence of pelvic node metastasis.
The  presence  of  palpable  adenopathy  is  associated  with 
proven metastases in 50%of patients. In the remainder,lymph 
node enlargement is secondary to inflammation. Persistent 
adenopathy after treatment of the primary lesion and 4 to 6 
weeks  of  antibiotic  therapy  are  the  consequence  of 
metastatic disease in 70-86%25,29
Several controversial issues remain regarding the treatment 
of regional nodes.
Complications of Lymphadenectomy:
The reluctance to offer prophylactic lymphadenectomy to all 
patients ,taking into the fact that patients with “minimal” 
nodal metastasis, as discussed above,have a 5yrs survival 
of approximately 80% ,which is unique to penile cancer as 
opposed to other genitourinary cancers like bladder,renal 
and prostate cancer 9with the exception of testicular germ 
cell tumors),because of the morbidity that the procedure 
can  produce,  as  opposed  to  the  relatively  limited 
postoperative  morbidity  of  retoperitoneal  and  pelvic 
lymphadenectomies.
Data  from  five  series  including  two  from  our  own 
institution,reveal minor complications in the range of 60% 
and  major  compications  in  about  40%  of  patients.31,  32, 
33.Lymphedema occurs in 25-50% patients, skin edge necrosis 
in 8% -62%,seroma formation in 6-16% and mortality in about 
1.5%, in different series.Complications and mortality have 
been  found  to  be  more  frequent  in  palliative  inguinal 
dissections and hence the risk –benefit ration should be 
carefully weighed in this subgroup of patients.
Post  operative  complications  have  been  reduced  with 
improvement  in  pre  and  postoperative  care,  improved 
surgical  techniques  including  plastic  surgical 
reconstruction  and  modifications  of  the  extent  of 
dissection34.  If  all  node  negative  patients  were  offered 
lymphadenectomy  ,  70  %  of  the  patients  undergoing  the 
procedure will not benefit from it.
Delayed Lymphadenectomy:
From  the  above  discussion,it  is  clear  that  inguinal 
dissection is not a trivial concern and that it because of 
its morbitity, it cannot be offered to all node negative 
patients  prophylactically.  The  most  striking  question, 
next, is whether a “delayed” lymphadenectomy performed when 
nodes become clinically palpable has the same outcome as in 
patients who are clinically node negative and are offered 
prophylactic lymphadenectomy. Data from five contemporary 
series  including  a  large  series  from  our  own 
institution35show  that  the  5  years  survival  in  the 
surveillance  group  was  inferior  to  the  early 
lymphadenectomy group.35,25,36,37,38.
Predicting subgroups of patients who have a very low 
risk of inguinal node metastasis, and therefore can be kept 
on  surveillance  rather  than  being  offered  prophylactic 
lymphadenectomy has been addressed by a few authors. In the 
series of Solsona et al27,the patients were risk stratified 
based  on  primary  tumor  stage  and  grade  into  low, 
intermediate  and  high  risk  categories(vide  supra).In  the 
low  and  high  risk  categories,  only  8%  of  unnecessary 
lymphadenectomies  were  performed(2  patients)  but  in  the 
intermediate risk group,prophylactic lymphadenectomy would 
have  been  unnecessary  in  66.6.  %  of  the  patients. 
Obviously, additional parameters are required in order to 
further risk stratify this subgroup, like, lymphovascular 
invasion and growth pattern. Similar results are reported 
by Mc Dougal16. when the primary tumor invades the corpus 
spongiosum or cavernosum or were poorly differentiated, 83% 
progressed  to  regional  node  involvement..  of  the 
individuals  with  palpably  negative  nodes,  78%  had 
micrometastasis. On the other hand when the primary tumor 
was well or moderately differentiated, and did not involve 
the  corpora,  only  4  patients  had  regional  lymph  node 
metastasis.
MODIFIED INGUINAL DISSECTION:
A  complete  modified  inguinal  dissection  was  originally 
proposed by Catalona34 and involves a smaller skin incision, 
alimited field of inguinal dissection, preservation of the 
saphenous vein, and thicker skin flaps.Unlike superficial 
dissection,this  procedure  includes  removal  of  the  deep 
inguinal node in the fossa ovalis.
SENTINEL  LYMPH  NODE  BIOPSY  AND  INTRAOPERATIVE  LYMPHATIC 
MAPPING:
The  sentinel  lymph  node  biopsy  in  penile  cancers  was 
originally  described  by  Cabanas24 and  is  based  on 
lymphangiographic  studies.  In  this  series  when  this 
sentinel node was negative for tumor, metastases to other 
ilioinguinal nodes did not occur. Metastases to this node 
indicated the need for a complete ilioinguinal dissection. 
In Cabanas’ series 3 of 31 patients with negative sentinel 
node biopsy died of disease, giving a false negative rate 
of 10%. The false negative rate of this technique has been 
reported to be between 9% and 50% in different series36,39. 
Thus  biopsies  directed  to  an  anatomical  area  can  be 
unreliable and are no longer recommended.
The Netherlands cancer institute has published its series 
on  sentinel  node  biopsy  for  penile  carcinoma  using 
Intraoperative  lymphatic  mapping  with  the  dual  tracer 
technique in combination with lymphoscintigraphy and gamma 
ray detection  probe in  123 penile  cancer patients.40 The 
identification rate and sensitivity in their series are 98% 
and  82%  respectively.  Six  false  negative  cases  were 
identified and analyzed. In one, the groin was not explored 
because  lymphoscintigraphy  did  not  identify  the  sentinel 
node on this side. In a second patient, additional serial 
sectioning  and  immunohistochemistry  identified  the 
micrometastsis.  Blockage  and  rerouting  of  lymphatics  was 
thought to be the cause in three other patients and in 
another, no cause could be identified. Exploration for blue 
vessels  is  now  a  standard  procedure  in  case  of  no 
visualization on scintigram.
In yet another study of 153 node negative penile carcinoma 
patients41 there was improved survival in patients staged 
with sentinel node biopsy over those in the surveillance 
group. Disease specific 3 yrs surveillance in the sentinel 
lymph  node  versus  surveillance  groups  were  91%  and  79% 
respectively. The sentinel node was the only positive node 
in 74% of the patients. Morbidity of the procedure is low 
(7%)  and  in  the  above  study,  all  complications  were 
reported to resolve without long term sequelae.
RADIATION  THERAPY  IN  THE  MANAGEMENT  OF  CARCINOMA  OF  THE 
PENIS:
Radiation therapy for the primary tumor:
Radiotherapy can be successful for highly selected group of 
patients with small superficial tumors who wish to retain 
their penis. Radiation can be delivered as external beam 
therapy  or  as  brachytherapy.  Disadvantages  are  long 
duration  of  treatment  (external  beam  therapy), 
complications like urethral stricture, stenosis and fistula 
at  doses  needed  to  sterilize  the  tumor  (60  Gy).  As  an 
alternative to teletherapy, brachytherapy using Iridium192, 
Cesium137, and Radium 226 have been reported42.
Radiation therapy for the inguinal area:
Assessment of the inguinal area by primary radiotherapy is 
hampered by the uncertainty arising from the inaccuracy of 
clinical  staging  and  the  frequent  lack  of  histological 
confirmation of nodal metastasis. Another objection to te 
treatment  of  the  inguinal  node  metastases  is  that  the 
inguinal areas tolerate radiation poorly and are subject to 
skin maceration and ulceration.
Inguinal  radiotherapy  has  been  used  with  success  in  the 
neoadjuvant setting in the presence of nodes >4 cm30. In 
this series the incidence of extranodal spread ,which has 
shown  to  have  an  advers  impact  on  survival,was  33%  in 
unirradiated  groins  while  it  was  9%  in  patients  who 
received  40Gy  neoadjuvant  radiotherapy.  Radiotherapy  may 
also be useful in palliation of fixed ,inoperable inguinal 
nodes.
              MATERIALS AND METHODS.
Between 01.01.1991 and 31.12.2000, 312 patients were 
diagnosed, indexed and treated for squamous cell carcinoma 
of the penis. 208 of the 312 were clinically node negative 
to start with, 75 were clinically node positive and 29 had 
completed part of their treatment elsewhere and hence 
clinical “N” stage could not be assessed. The outcomes and 
prognostic factors of the entire group of patients as well 
as the node negative and node positive subgroups are 
analyzed individually. Further, factors associated with 
nodal metastasis in patients who were node negative upfront 
are analyzed and a risk stratification table based on 
incidence of nodal metastasis in node negative patients 
depending on primary tumor pathological “T” status and 
grade is made. Statistical analysis was done using the SPSS 
11.0.1 (15 nov 2001) statistical package.
RESULTS
Between 01.01.1991 and 31.12.2000, 312 patients with 
squamous cell carcinoma of the penis were indexed and 
treated at the Cancer Institute (WIA), Adayar, Chennai
Age distribution
The age range of these patients was between 21 years and 85 
years. The median age was 50 years.
Predisposing factors for penile cancer
Data on the possible predisposing factors including tobacco 
and alcohol abuse, phimosis, pre-existing condyloma, are 
presented in Table 1.
           Pathological “T” Status
Majority (87.5%) of the patients were treated only at 
CANCER INSTITUTE (WIA). However 12.5% of the patients 
received some form of treatment elsewhere, usually, 
penectomy. The pathological “T” status of these patients is 
shown in table 2.
Clinical “N” status at presentation.
All patients went through a history, physical examination, 
and ultrasound of the pelvis for enlarged pelvic nodes. 
Suspicious inguinal nodes were sampled by Fine Needle 
Aspiration Cytology (FNAC). Patients who had metastatic 
nodes as proven by FNAC underwent penectomy followed by 
staged Ilioinguinal block dissection or in certain 
situations simultaneous penectomy and lymphadenectomy. 
Patients who did not have clinically suspicious nodes or 
whose FNAC did not reveal malignant squamous cells 
underwent penectomy and 3 to 4 weeks of appropriate 
antibiotic therapy and were on a close surveillance 
protocol. They were followed up monthly over the first 
year, every two months over the second year, every three 
months over the third year and six monthly over the fourth 
and fifth year. From the start of the sixth year after 
diagnosis they were followed up annually. Some patients had 
a penectomy elsewhere and came to CANCER INSTITUTE (WIA) 
for various reasons including recurrence in the regional 
nodes or just for an opinion and follow up. The clinical 
“N” status of these patients was taken as “Nx” for 
analysis. So based on clinical examination at presentation 
and at end of penectomy patients were grouped into three 
for further study, namely, clinically node negative (cN0), 
clinically node positive (cN+), and clinically node status 
cannot be assessed (cNx). They were distributed as in table 
3.
   Treatment of the primary tumor.
Most patients underwent partial penectomy. The surgery was 
typically done under spinal anesthesia during the early 
1990s. But towards the late 90s, the procedure was done 
under local anesthesia with sedation. If any of the margins 
were positive after partial penectomy, then a total 
penectomy was done. Patients who had large volume disease 
involving the shaft and for whom a penile stump of at least 
2 cm could not be obtained underwent total penectomy. Few 
patients had localized tumors that could be treated with 
circumcision, wide local excision or radiation therapy in 
the form of iridium implants or external radiation with 
electrons or x-rays. (Table 4)
Grade of the primary tumor.
The primary tumor grade as assigned using the three tier 
grading system is shown in table 5.
Survival. 
The 5 years overall survival of the entire group of 312 
patients was 67%. The survival curve is shown in chart 1.
Univariate analysis of factors affecting survival 
Survival of these patients with respect to primary tumor 
pathological “T” status, clinical “N” status, final 
pathological “N” status, grade of primary tumor, type of 
penectomy performed were analyzed. The final pathological 
“N” status was defined as follows:
a) Clinically node positive patients who underwent 
lymphadenectomy and had pathologically metastatic nodes
b) Clinically node positive patients who had unresectable 
metastatic nodes confirmed by FNAC and were offered 
lymphadenectomy but the patient refused surgery, or were 
offered supportive treatment or were treated with 
radiotherapy
c) Clinically node negative patients who recurred in the 
regional nodes during follow up and fell into either one of 
the above groups.
On Univariate analysis all the 5 factors were statistically 
significant predictors of survival. It should be noted that 
there were three subgroups with respect to treatment of the 
primary tumor. The third group as shown in the table 6 
included 23 patients with circumcision, wide excision, and 
radiotherapy. The difference in overall survival between 
this group and the partial penectomy group did not reach 
statistical significance (p=0.12).
The difference between the “cNx” and “cN+” patients was 
also not statistically significant. (p=0.06).
In multivariate analysis of these five factors, only the 
final pathological “N” status, grade of the primary tumor 
and pathological “T” status were statistically significant 
predictors of survival. 
Clinically Node Negative at Presentation
Among the total of 312 patients, 208 were clinically node 
negative at presentation or at assessment after penectomy.
Their outcome is described in table 8. Their final “N” 
status is tabulated in table 9.
The 5-year overall survival of this group of patients was 
81%. The survival curve is shown in chart 3.
35 of the 208 (17%) developed some form of recurrence 
(local, regional, local+ regional, distant). Ultimately 33 
of the 208 patients (15.8%) failed in the regional nodes at 
some point during follow up. 8(24%) of these patients 
developed unresectable nodes and received either supportive 
care or radiotherapy to the nodes. The final pathological 
“N” status as a predictor of overall survival is shown in 
table 10.  The difference in survival between the final 
“N0” and pN1 group was not statistically significant 
(p=0.20).
Factors influencing survival in clinically “N0” patients
The pathological “T” status, Grade of primary tumor, 
treatment of primary tumor, whether the patient developed 
either local, regional or distant recurrence or the final 
pathological “N” status were analyzed for their effect on 
overall survival. The results are shown in table 11.
In multivariate analysis, using the Cox Regression method, 
only the final pathological “N” status and the development 
of any recurrence significantly influenced survival (Table 
12).
Whether recurrence could be predicted using combinations of 
primary tumor grade and pathological “T” status was 
analyzed. The results are shown in table 13. 
The time to recurrence did not have any statistically 
significant influence on overall survival (p=0.16%).
Clinically Node Positive at presenatation.
The distribution of 75 patients who were clinically node 
positive at presentation is shown in table 15.
The 5 years overall survival of this group of patients was 
40%.
Univariate analysis of the following factors, namely, 
Pathological “T” status, treatment of the primary penile 
tumor, grade of primary tumor, pathological node status, 
unilateral or bilateral nodes and presence of extra nodal 
spread were analyzed for their influence on overall 
survival. The results are displayed in table 16. 
The pathological node status and presence of extra nodal 
spread were the only statistically significant predictors 
of survival in this group.
On multivariate analysis only the pathological node status 
was found to statistically significant factor influencing 
survival.
Note that 7 patients had pathologically No status after 
groin dissection.
Table 1. 
Predisposing factors
Predisposing 
factors 
Frequency Percent
 No risk factors 128 41.0
 Tobacco only 98 31.4
 Alcohol only 4 1.3
 Tobacco and 
Alcohol
72 23.1
 Phimosis with or 
without other 
factors
9 2.9
 Condyloma 1 .3
 Total 312 100.0
 
Table 2
Pathological “T” status
Pathological “T” 
status 
Frequency Percent
 pT1 40 12.8
 pT2 191 61.2
 pT3 36 11.5
 pT4 4 1.3
 pTis 1 .3
 pTx 40 12.8
 Total 312 100.0
 
Table 3
Clinical “N” status upfront
cN status number
cN0 208
cN+ 75
cNx 29
Table 4
Treatment of the primary tumor
Treatment of 
primary tumor
Frequency Percent
 Partial 
penectomy
222 71.2
 Total Penectomy 61 19.6
 Conversion to 
Total penectomy 
because of 
positive margins
5 1.6
 Circumcision 14 4.5
 Wide excision 2 .6
 Iridium 
implantation
2 .6
 External RT-
electrons
3 1.0
 External RT-X-
rays
2 .6
 Conversion to 
partial penectomy
1 .3
 Total 312 100.0
 
Table 5
Grade of primary tumor
Grade of primary 
tumor 
Frequency Percent
 grade 1 119 38.1
 grade 2 105 33.7
 grade 3 74 23.7
 not available 14 4.5
 Total 312 100.0
 
Chart 1
Survival curve for the entire group of 312 patients (n=312)
years since penectomy
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Table 6
Univariate analysis of factors influencing survival of the 
entire group of 312 patients.
Factor 5-yr survival P value
Final pathological “N0”
Final pathological “N+”
89%
39%
<0.0001
pTis and pT1
pT2
pT3 and pT4
89%
71%
44%
0.0004
Grade 1
Grade 2
Grade 3
86%
66%
48%
<0.0001
Partial Penectomy
Total Penectomy
Circumcision, Wide 
Excision, RT *
71%
48%
85%
<0.0001
Clinically N0
Clinically N+
Clinically Nx
81%
40%
46%
<0.0001
Table 7
Multivariate analysis of significant factors from table 6, 
by the Cox Regression method.
factor p value
 Final pathological "N" 
status
.000
 p"T" status .040
 Treatment of primary tumor .752(NS)
 Grade of primary tumor .011
 C “N” status .594(NS)
Table 8 
Clinically “N0”(c “N0”) upfront.
Subgroup number
Nodes observed, no recurrence till last follow up 168
Prophylactic Lymphadenectomy 2
First recurrence in nodes 26
First recurrence only in primary tumor site 4
First recurrence both in primary tumor site and 
nodes
4
First recurrence –distant metastasis 1
Suspected nodal recurrence, lymphadenectomy done, 
pathologically N0
3
Total 208
Chart 2
Survival curve for patients who were clinically “N0” 
upfront.(n=208)
years after penectomy
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Table 9
Final pathological “N” status of patients who were c “N0” 
upfront
 Frequency Percent
 N0 175 84.1
 pN1 12 5.8
 pN2 8 3.8
 pN3 4 1.9
 Unresectable 
nodes
8 3.8
 pNx 1 .5
 Total 208 100.0
 
Chart 3
Survival curve of c “N0” patients who failed in the 
regional nodes. (n=33)
years after penectomy
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Table 10
Survival of c “N0” patients according to final pathological 
“N” status.
Subgroup 5-yrs overall 
survival
P value
Final pathological 
“N0”
89% Overall comparison 
P<0.0001
P “N1” 83%
P ‘N2” 37%
P “N3” 0%
Unresectable nodes 13%
Table 11
Univariate analysis of factors affecting survival in c “N0” 
patients.
Factor 5-yr 
overall 
survival
P value
Final pathological “N0”
pN1
pN2
pN3
unresectable nodes
89%
83%
37%
0%
13%
P<0.0001
Grade1
Grade2
Grade3
88%
80%
66%
P=0.01
Partial penectomy
Total penectomy
Circumcision, wide excision, RT
83%
66%
100%
P=0.007
pTis and pT1
pT2
pT3 and pT4
91%
81%
63%
P=0.2(NS)
No recurrence
Any recurrence
91%
44%
P<0.0001
Table 12
Multivariate analysis of significant factors from table 11, 
using Cox Regression method
factor p value
 Final pathological "N" 
status
.003
 recurrence .007
 treatment of primary tumor .064(NS)
 grade of primary tumor .396(NS)
 
Table 13
Predicting recurrence based on pathological “T” status and 
grade of primary tumor in patients who were c “N0” upfront.
Factor no.recurred/total no. percentage
pT3,4 and Grade3
pT1,2 and Grade 3
4/11
10/28
36%
36%
pT3,4  Grade2 
pT1,2  Grade2
2/7
10/59
29%
17%
pT3,4   Grade 1
pT1,2   Grade 1
1/11
6/92
9%
7%
Table 14
Time to recurrence in patients who were c “N0” upfront
Time to recurrence
 
Frequency Percent
 1 to 6 months 25 71%
 7 to 12 months 5 14.5%
 13 and more months 5 14.5%
 Total 35 100.0
 
Table 15
Clinically “N+” patients
Subgroup number
Groin dissection done 66
Unresectable nodes treated with RT 4
Patient unwilling for surgery 5
Total 75
Chart 4
Survival curve of c “N+” patients (n=75)
years after penectomy
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Table 16
Univariate analysis of factors affecting survival in c “N+” 
patients (n=75)
Variable 5 years overall 
survival
P value
pTis and pT1
pT2
pT3
67%
42%
32%
0.62 (NS)
Grade 1
Grade 2
Grade 3
62%
43%
30%
0.29 (NS)
Partial penectomy
Total penectomy
47%
28% 0.16 (NS)
pN0
pN1
pN2
pN3
69%
60%
47%
26%
0.01
Unilateral nodes
Bilateral nodes
40%
32% 0.30 (NS)
No ENS*
ENS present
88%
33% 0.004
*ENS- Extra Nodal Spread.
Table 17.
Multivariate analysis of significant factors in table 16.
variable p value
 p "N" status .000
           Extra Nodal 
Spread
.772 (NS)
 
Table 18.
 Pattern of node metastasis in cN+ patients as a function 
of the grade of primary tumor and pathological “T” status
  grade    Total
   grade 1 grade 2 grade 3 not 
availab
le
 
 pT pT1 1  1  2
  pT2 6 19(28%) 16(24%)  41
  pT3  8 8  16
  pT4  1 2  3
  pTx  2 2 2 6
 Total  7(10%) 30(44%) 29(43%) 2 68
 
                        DISCUSSION
Squamous cell carcinoma of the penis has a crude incidence 
rate of 0.88/100,000 population in India. The incidence in 
the Madras Metropolitan Registry is the highest among all 
cancer registries in India (1.43/100,000)8.
Factors predisposing to the development of penile cancer 
are well documented10-15. In this study 55% of the patients 
consumed either alcohol, or tobacco or both. Phimosis was 
present in 3% and one patient had a condyloma.
The majority of patients had pathological “T” stage, pT2 
(61%).
Majority of the patients had Grade 1 or Grade 2 tumors 
(71.8%). Grade 3 tumors comprised 23.7% of the patients.
208 patients (67%) were clinically node negative (cN0) at 
presentation. 75 (24%) were clinically node positive (cN+) 
and for 29 (9%) their, clinical “N” stage could not be 
assessed (cNx).
 It is the policy at Cancer institute (WIA) to offer 
lymphadenectomy only if the nodes are clinically 
significant after 3 to 4 weeks of antibiotics post 
penectomy. Prophylactic lymphadenectomy is not practiced. 
Ultimately, only 33 patients (15.8%) of the 208, cN0 
patients failed in the nodes. False negative clinical 
evaluation for inguinal nodal metastasis has been reported 
to be between 20 and 40% by different authors25, 27. However 
with careful clinical examination and meticulous “active” 
follow up, as followed in our hospital, this can be kept as 
low as 15%. Conversely, pathological N0 in patients who had 
clinically significant nodes and underwent lymphadenectomy 
have been reported to occur in 40 to 50% of patients43. 
However, in the present study, only 7 patients (9%) 
belonged to this group.
There has been no randomized controlled trial to address 
the issue of prophylactic lymphadenectomy in node negative 
patients. From this study, it is evident that about 15% of 
clinically N0 patients will eventually fail in the nodes. 
So, offering prophylactic lymphadenectomy will expose 85% 
of the patients unnecessarily to the morbidity of groin 
dissection.
The 5 year survival of the entire group of 312 patients was 
67%. The Final “N” status, pathological “T” status and 
grade of the primary tumor were the statistically 
significant predictors of survival on multivariate 
analysis. Similar results have been discussed by Lopes et 
al44. 
The 5 years overall survival of the node negative group was 
81%. Similar figures have been reported by others also25, 44, 
27. However the survival of the upfront cN0 patients, but 
who recurred in the nodes during follow up was 44%. This 
did not differ from the 5 years survival of the patients 
who were node positive at presentation and underwent groin 
dissection.
In the clinically N0, group, the only factor which affected 
survival was development of recurrent disease in the 
inguinal nodes.
The 5 years overall survival in the clinically node 
positive group was 40%. This is marginally better than 
quoted by Ornellas et al (29%) 25 and by Whitmore and 
Vagaiwala (35%) 45.
In the clinically N+, group, the pathological “N” status 
was the only factor which affected survival in multivariate 
analysis
Solsona et al have attempted to risk stratify patients 
based on pathological “T” status and Grade of the primary 
tumor in order to predict incidence of lymph node 
metastasis group wise27.In this study also a similar attempt 
was made to predict nodal metastasis using tumor stage and 
grade as predictive factors. It was found that maximum risk 
of recurrence in the nodes, in patients who are clinically 
node negative, was with the group pT3,4 Grade 3(36%) and 
pT1,2 grade 3(36%), the least, for pT1,2 grade 1 tumors 
(7%).( vide table 13). Among the cN+ group, grade 2 and 
grade 3 tumors accounted for 90% of the patients and grade 
1 tumors accounted for 10 % of the patients (vide table 
18). 
 
   CONCLUSION
It is evident from this study that the nodal status is the 
single  most  important  factor  affecting  survival  in  all 
penile cancer patients. Among the node negative patients, 
development  of  recurrence  in  the  nodes  is  the  most 
important prognostic factor. In node positive patients, the 
extent  of  nodal  involvement  as  represented  by  the 
pathological “N” status is the most important prognostic 
factor.  The  policy  of  observation  of  clinically  node 
negative  patients  after  penectomy  has  been  validated  in 
this study. Only 15% of this group ultimately failed in the 
nodes. The 5 years overall survival was the same in both 
the clinically node positive patients who presented upfront 
and the clinically node negative patients who were observed 
but failed in the nodes. The time to recurrence did not 
significantly affect survival. 
5 years overall survival rates of node negative and node 
positive  patients  in  this  study  are  comparable  to  those 
reported in contemporary series.
Further, among the clinically node negative patients, 36% 
of pT3,4 grade 3 tumors and 36% of pT1,2 Grade 3 tumors, 
failed  in  the  nodes.  Hence,  this  may  be  a  subgroup  of 
patients  who  will  benefit  from  prophylactic 
lymphadenectomy. It has to be studied prospectively whether 
such a measure will improve the survival of these patients. 
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